Skin Cancer Diagnostics Using Photoacoustic Imaging

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this clinical study, photoacoustic imaging will be used on patients with suspected skin cancer (primarily melanoma, basal cell carcinoma, and squamous cell carcinoma) to determine the tumor borders both superficially and at a depth.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transient Infrared Imaging for Early Detection of Skin Cancer

NCT02154451

Skin Cancer

UNKNOWN PHASE1/PHASE2

Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

NCT02379039

Squamous Carcinoma Head and Neck Cancer Anal Cancer +3 more

COMPLETED

Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer

NCT04110249

Head and Neck Carcinoma Head and Neck Lymph Node Head and Neck Squamous Cell Carcinoma +2 more

TERMINATED NA

Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

NCT03829033

Tonsil Cancer

RECRUITING NA

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

NCT03353077

Skin Squamous Cell Carcinoma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will employ multispectral photoacoustic imaging in the spectral range between 680-970 nm to scan suspected skin tumors both in vivo and ex vivo. The hyperspectral data will then undergo rigorous spectral analysis with the objective to identify the spectral fingerprints associated with healthy tissue and tumor. Thereafter, a classification algorithm will be used to determine whether a pixel in the acquired image more likely identifies with healthy tissue or tumor, which is then repeated for all pixels in the images. As such, a 3D image can be reconstructed in which the tumor is visibly contrasted from healthy tissue. Achieving this goal will facilitate the diagnostic procedures and greatly reduce waiting times, clinical costs and potential patient suffering.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with suspected skin tumors

With the help of photoacoustic imaging (PAI), determine the border between healthy tissue and tumor by determining the difference in chromophoric composition by their difference in absorption spectral features.

No interventions assigned to this group